{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,13]],"date-time":"2026-11-13T22:11:46Z","timestamp":1794607906177,"version":"4.9.1"},"reference-count":54,"publisher":"Springer Science and Business Media LLC","issue":"3","license":[{"start":{"date-parts":[[2021,1,7]],"date-time":"2021-01-07T00:00:00Z","timestamp":1609977600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2021,1,7]],"date-time":"2021-01-07T00:00:00Z","timestamp":1609977600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"funder":[{"DOI":"10.13039\/100003011","name":"Immune Deficiency Foundation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100003011","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Clin Immunol"],"published-print":{"date-parts":[[2021,4]]},"DOI":"10.1007\/s10875-020-00957-6","type":"journal-article","created":{"date-parts":[[2021,1,7]],"date-time":"2021-01-07T08:11:48Z","timestamp":1610007108000},"page":"610-620","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":14,"title":["Characterization of Infants with Idiopathic Transient and Persistent T Cell Lymphopenia Identified by Newborn Screening\u2014a Single-Center Experience in New York State"],"prefix":"10.1007","volume":"41","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-3346-7243","authenticated-orcid":false,"suffix":"III","given":"Artemio M.","family":"Jongco","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Robert","family":"Sporter","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elise","family":"Hon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Omer","family":"Elshaigi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shouling","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Foysal","family":"Daian","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Emily","family":"Bae","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Amanda","family":"Innamorato","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Catherine","family":"Capo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Brianne","family":"Navetta-Modrov","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David W.","family":"Rosenthal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vincent R.","family":"Bonagura","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2021,1,7]]},"reference":[{"issue":"3","key":"957_CR1","doi-asserted-by":"publisher","first-page":"338","DOI":"10.1542\/peds.32.3.338","volume":"32","author":"R Guthrie","year":"1963","unstructured":"Guthrie R, Susi A. A simple phenylalanine method for detecting phenylketonuria in large populations of newborn infants. Pediatrics. 1963;32(3):338\u201343.","journal-title":"Pediatrics."},{"issue":"22","key":"957_CR2","doi-asserted-by":"publisher","first-page":"2465","DOI":"10.1001\/jama.2009.1806","volume":"302","author":"JM Routes","year":"2009","unstructured":"Routes JM, Grossman WJ, Verbsky J, Laessig RH, Hoffman GL, Brokopp CD, et al. Statewide newborn screening for severe T-cell lymphopenia. JAMA. 2009;302(22):2465\u201370.","journal-title":"JAMA."},{"issue":"Suppl 2","key":"957_CR3","doi-asserted-by":"publisher","first-page":"S273","DOI":"10.1007\/s10545-010-9103-9","volume":"33","author":"AM Comeau","year":"2010","unstructured":"Comeau AM, Hale JE, Pai SY, Bonilla FA, Notarangelo LD, Pasternack MS, et al. Guidelines for implementation of population-based newborn screening for severe combined immunodeficiency. J Inherit Metab Dis. 2010;33(Suppl 2):S273\u201381.","journal-title":"J Inherit Metab Dis"},{"issue":"9","key":"957_CR4","doi-asserted-by":"publisher","first-page":"1466","DOI":"10.1373\/clinchem.2010.144915","volume":"56","author":"JL Gerstel-Thompson","year":"2010","unstructured":"Gerstel-Thompson JL, Wilkey JF, Baptiste JC, Navas JS, Pai SY, Pass KA, et al. High-throughput multiplexed T-cell-receptor excision circle quantitative PCR assay with internal controls for detection of severe combined immunodeficiency in population-based newborn screening. Clin Chem. 2010;56(9):1466\u201374.","journal-title":"Clin Chem"},{"issue":"2","key":"957_CR5","doi-asserted-by":"publisher","first-page":"535","DOI":"10.1016\/j.jaci.2010.10.013","volume":"127","author":"D Accetta","year":"2011","unstructured":"Accetta D, Syverson G, Bonacci B, Reddy S, Bengtson C, Surfus J, et al. Human phagocyte defect caused by a Rac2 mutation detected by means of neonatal screening for T-cell lymphopenia. J Allergy Clin Immunol. 2011;127(2):535\u20138.e1\u20132.","journal-title":"J Allergy Clin Immunol"},{"issue":"7","key":"957_CR6","doi-asserted-by":"publisher","first-page":"729","DOI":"10.1001\/jama.2014.9132","volume":"312","author":"A Kwan","year":"2014","unstructured":"Kwan A, Abraham RS, Currier R, Brower A, Andruszewski K, Abbott JK, et al. Newborn screening for severe combined immunodeficiency in 11 screening programs in the United States. JAMA. 2014;312(7):729\u201338.","journal-title":"JAMA."},{"issue":"3","key":"957_CR7","doi-asserted-by":"publisher","first-page":"289","DOI":"10.1007\/s10875-014-0006-7","volume":"34","author":"BH Vogel","year":"2014","unstructured":"Vogel BH, Bonagura V, Weinberg GA, Ballow M, Isabelle J, DiAntonio L, et al. Newborn screening for SCID in New York State: experience from the first two years. J Clin Immunol. 2014;34(3):289\u2013303.","journal-title":"J Clin Immunol"},{"issue":"6","key":"957_CR8","doi-asserted-by":"publisher","first-page":"579","DOI":"10.1080\/17474086.2016.1180243","volume":"9","author":"BJ Buelow","year":"2016","unstructured":"Buelow BJ, Verbsky JW, Routes JM. Newborn screening for SCID: lessons learned. Expert Rev Hematol. 2016;9(6):579\u201384.","journal-title":"Expert Rev Hematol"},{"key":"957_CR9","doi-asserted-by":"crossref","unstructured":"Amatuni GS, Currier RJ, Church JA, Bishop T, Grimbacher E, Nguyen AA, et al. Newborn Screening for Severe Combined Immunodeficiency and T-cell Lymphopenia in California, 2010\u20132017. Pediatrics. 2019;143(2).","DOI":"10.1542\/peds.2018-2300"},{"key":"957_CR10","doi-asserted-by":"publisher","first-page":"119","DOI":"10.1186\/1479-5876-11-119","volume":"11","author":"F Serana","year":"2013","unstructured":"Serana F, Chiarini M, Zanotti C, Sottini A, Bertoli D, Bosio A, et al. Use of V(D)J recombination excision circles to identify T- and B-cell defects and to monitor the treatment in primary and acquired immunodeficiencies. J Transl Med. 2013;11:119.","journal-title":"J Transl Med"},{"issue":"1","key":"957_CR11","doi-asserted-by":"publisher","first-page":"82","DOI":"10.1007\/s10875-011-9609-4","volume":"32","author":"JW Verbsky","year":"2012","unstructured":"Verbsky JW, Baker MW, Grossman WJ, Hintermeyer M, Dasu T, Bonacci B, et al. Newborn screening for severe combined immunodeficiency; the Wisconsin experience (2008-2011). J Clin Immunol. 2012;32(1):82\u20138.","journal-title":"J Clin Immunol"},{"issue":"3","key":"957_CR12","doi-asserted-by":"publisher","first-page":"622","DOI":"10.1016\/j.jaci.2011.12.004","volume":"129","author":"J Verbsky","year":"2012","unstructured":"Verbsky J, Thakar M, Routes J. The Wisconsin approach to newborn screening for severe combined immunodeficiency. J Allergy Clin Immunol. 2012;129(3):622\u20137.","journal-title":"J Allergy Clin Immunol"},{"issue":"3","key":"957_CR13","doi-asserted-by":"publisher","first-page":"194","DOI":"10.1053\/j.semperi.2015.03.004","volume":"39","author":"A Kwan","year":"2015","unstructured":"Kwan A, Puck JM. History and current status of newborn screening for severe combined immunodeficiency. Semin Perinatol. 2015;39(3):194\u2013205.","journal-title":"Semin Perinatol"},{"issue":"1","key":"957_CR14","doi-asserted-by":"publisher","first-page":"241","DOI":"10.1111\/imr.12729","volume":"287","author":"JM Puck","year":"2019","unstructured":"Puck JM. Newborn screening for severe combined immunodeficiency and T-cell lymphopenia. Immunol Rev. 2019;287(1):241\u201352.","journal-title":"Immunol Rev"},{"key":"957_CR15","doi-asserted-by":"publisher","first-page":"36","DOI":"10.1016\/j.clim.2017.07.002","volume":"183","author":"S Albin-Leeds","year":"2017","unstructured":"Albin-Leeds S, Ochoa J, Mehta H, Vogel BH, Caggana M, Bonagura V, et al. Idiopathic T cell lymphopenia identified in New York State Newborn Screening. Clin Immunol. 2017;183:36\u201340.","journal-title":"Clin Immunol"},{"key":"957_CR16","doi-asserted-by":"publisher","first-page":"584","DOI":"10.1007\/s12098-019-02904-9","volume":"86","author":"J Aluri","year":"2019","unstructured":"Aluri J, Gupta MR, Dalvi A, Mhatre S, Kulkarni M, Desai M, et al. Lymphopenia and severe combined immunodeficiency (SCID) - think before you ink. Indian J Pediatr. 2019;86:584\u20139.","journal-title":"Indian J Pediatr"},{"key":"957_CR17","doi-asserted-by":"publisher","first-page":"156","DOI":"10.3389\/fped.2017.00156","volume":"5","author":"X Rios","year":"2017","unstructured":"Rios X, Chinn IK, Orange JS, Hanson CI, Rider NL. T-cell lymphopenia detected by newborn screening in two siblings with an Xq13.1 duplication. Front Pediatr. 2017;5:156.","journal-title":"Front Pediatr"},{"issue":"6","key":"957_CR18","doi-asserted-by":"publisher","first-page":"586","DOI":"10.1097\/ACI.0000000000000586","volume":"19","author":"M Patrawala","year":"2019","unstructured":"Patrawala M, Kobrynski L. Nonsevere combined immunodeficiency T-cell lymphopenia identified through newborn screening. Curr Opin Allergy Clin Immunol. 2019;19(6):586\u201393.","journal-title":"Curr Opin Allergy Clin Immunol"},{"issue":"5","key":"957_CR19","doi-asserted-by":"publisher","first-page":"424","DOI":"10.1016\/j.anai.2019.08.006","volume":"123","author":"LJ Kobrynski","year":"2019","unstructured":"Kobrynski LJ. Identification of non-severe combined immune deficiency T-cell lymphopenia at newborn screening for severe combined immune deficiency. Ann Allergy Asthma Immunol. 2019;123(5):424\u20137.","journal-title":"Ann Allergy Asthma Immunol"},{"issue":"1","key":"957_CR20","first-page":"46","volume":"22","author":"M Gholamin","year":"2015","unstructured":"Gholamin M, Bazi A, Abbaszadegan MR. Idiopathic lymphopenia. Curr Opin Hematol. 2015;22(1):46\u201352.","journal-title":"Curr Opin Hematol"},{"issue":"5","key":"957_CR21","doi-asserted-by":"publisher","first-page":"973","DOI":"10.1016\/j.jaci.2003.07.003","volume":"112","author":"WT Shearer","year":"2003","unstructured":"Shearer WT, Rosenblatt HM, Gelman RS, Oyomopito R, Plaeger S, Stiehm ER, et al. Lymphocyte subsets in healthy children from birth through 18 years of age: the Pediatric AIDS Clinical Trials Group P1009 study. J Allergy Clin Immunol. 2003;112(5):973\u201380.","journal-title":"J Allergy Clin Immunol"},{"issue":"1","key":"957_CR22","doi-asserted-by":"publisher","first-page":"81","DOI":"10.1083\/jcb.201101030","volume":"193","author":"C Baldeyron","year":"2011","unstructured":"Baldeyron C, Soria G, Roche D, Cook AJ, Almouzni G. HP1alpha recruitment to DNA damage by p150CAF-1 promotes homologous recombination repair. J Cell Biol. 2011;193(1):81\u201395.","journal-title":"J Cell Biol"},{"issue":"17","key":"957_CR23","doi-asserted-by":"publisher","first-page":"9203","DOI":"10.1074\/jbc.M115.713271","volume":"291","author":"E Rodriges Blanko","year":"2016","unstructured":"Rodriges Blanko E, Kadyrova LY, Kadyrov FA. DNA mismatch repair interacts with CAF-1- and ASF1A-H3-H4-dependent histone (H3-H4)2 tetramer deposition. J Biol Chem. 2016;291(17):9203\u201317.","journal-title":"J Biol Chem"},{"issue":"2","key":"957_CR24","doi-asserted-by":"publisher","first-page":"621","DOI":"10.1053\/j.gastro.2011.04.056","volume":"141","author":"D Takahashi","year":"2011","unstructured":"Takahashi D, Hase K, Kimura S, Nakatsu F, Ohmae M, Mandai Y, et al. The epithelia-specific membrane trafficking factor AP-1B controls gut immune homeostasis in mice. Gastroenterology. 2011;141(2):621\u201332.","journal-title":"Gastroenterology."},{"issue":"2","key":"957_CR25","doi-asserted-by":"publisher","first-page":"273","DOI":"10.1016\/S1097-2765(01)00175-7","volume":"7","author":"AA Davies","year":"2001","unstructured":"Davies AA, Masson JY, McIlwraith MJ, Stasiak AZ, Stasiak A, Venkitaraman AR, et al. Role of BRCA2 in control of the RAD51 recombination and DNA repair protein. Mol Cell. 2001;7(2):273\u201382.","journal-title":"Mol Cell"},{"issue":"15","key":"957_CR26","doi-asserted-by":"publisher","first-page":"8644","DOI":"10.1073\/pnas.151253498","volume":"98","author":"F Xia","year":"2001","unstructured":"Xia F, Taghian DG, DeFrank JS, Zeng ZC, Willers H, Iliakis G, et al. Deficiency of human BRCA2 leads to impaired homologous recombination but maintains normal nonhomologous end joining. Proc Natl Acad Sci U S A. 2001;98(15):8644\u20139.","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"4","key":"957_CR27","doi-asserted-by":"publisher","first-page":"959","DOI":"10.1016\/j.ajhg.2008.02.017","volume":"82","author":"C Bergmann","year":"2008","unstructured":"Bergmann C, Fliegauf M, Br\u00fcchle NO, Frank V, Olbrich H, Kirschner J, et al. Loss of nephrocystin-3 function can cause embryonic lethality, Meckel-Gruber-like syndrome, situs inversus, and renal-hepatic-pancreatic dysplasia. Am J Hum Genet. 2008;82(4):959\u201370.","journal-title":"Am J Hum Genet"},{"issue":"1","key":"957_CR28","doi-asserted-by":"publisher","first-page":"106","DOI":"10.1016\/j.clim.2004.02.008","volume":"112","author":"EH Moylett","year":"2004","unstructured":"Moylett EH, Wasan AN, Noroski LM, Shearer WT. Live viral vaccines in patients with partial DiGeorge syndrome: clinical experience and cellular immunity. Clin Immunol. 2004;112(1):106\u201312.","journal-title":"Clin Immunol"},{"issue":"6","key":"957_CR29","doi-asserted-by":"publisher","first-page":"519","DOI":"10.1136\/adc.2006.097493","volume":"96","author":"V Waters","year":"2007","unstructured":"Waters V, Peterson KS, LaRussa P. Live viral vaccines in a DiGeorge syndrome patient. Arch Dis Child. 2007;96(6):519\u201320.","journal-title":"Arch Dis Child"},{"key":"957_CR30","doi-asserted-by":"publisher","first-page":"357","DOI":"10.1016\/B978-0-12-816768-7.00013-2","volume-title":"Stiehm\u2019s Immune Deficiencies","author":"ML Markert","year":"2020","unstructured":"Markert ML. Defects in thymic development. In: Sullivan KE, Stiehm RE, editors. Stiehm\u2019s Immune Deficiencies. Second ed. London: Elsevier; 2020. p. 357\u201380.","edition":"Second"},{"issue":"4","key":"957_CR31","doi-asserted-by":"publisher","first-page":"e325","DOI":"10.1542\/peds.112.4.e325","volume":"122","author":"EE Perez","year":"2003","unstructured":"Perez EE, Bokszczanin A, McDonald-McGinn D, Zackai EH, Sullivan KE. Safety of live viral vaccines in patients with chromosome 22q11.2 deletion syndrome (DiGeorge syndrome\/velocardiofacial syndrome). Pediatrics. 2003;122(4):e325.","journal-title":"Pediatrics"},{"issue":"14","key":"957_CR32","doi-asserted-by":"publisher","first-page":"1668","DOI":"10.1016\/j.vaccine.2004.10.005","volume":"23","author":"C Azzari","year":"2005","unstructured":"Azzari C, Gambineri E, Resti M, Moriondo M, Betti L, Saldias LR, et al. Safety and immunogenicity of measles-mumps-rubella vaccine in children with congenital immunodeficiency (DiGeorge syndrome). Vaccine. 2005;23(14):1668\u201371.","journal-title":"Vaccine."},{"issue":"6","key":"957_CR33","doi-asserted-by":"publisher","first-page":"1194","DOI":"10.1016\/j.jaci.2008.06.039","volume":"122","author":"CM Davis","year":"2008","unstructured":"Davis CM, Kancherla VS, Reddy A, Chan W, Yeh HW, Noroski LM, et al. Development of specific T-cell responses to Candida and tetanus antigens in partial DiGeorge syndrome. J Allergy Clin Immunol. 2008;122(6):1194\u20139.","journal-title":"J Allergy Clin Immunol"},{"issue":"1","key":"957_CR34","doi-asserted-by":"publisher","first-page":"a007252","DOI":"10.1101\/cshperspect.a007252","volume":"1","author":"RA Koup","year":"2011","unstructured":"Koup RA, Douek DC. Vaccine design for CD8 T lymphocyte responses. Cold Spring Harb Perspect Med. 2011;1(1):a007252.","journal-title":"Cold Spring Harb Perspect Med"},{"key":"957_CR35","unstructured":"https:\/\/www.health.ny.gov\/statistics\/vital_statistics\/ accessed 6\/20\/2020."},{"issue":"3","key":"957_CR36","doi-asserted-by":"publisher","first-page":"456","DOI":"10.1007\/s10875-020-00757-y","volume":"40","author":"MD Gans","year":"2020","unstructured":"Gans MD, Gavrilova T. Retrospective analysis of a New York newborn screen severe combined immunodeficiency referral center. J Clin Immunol. 2020;40(3):456\u201365.","journal-title":"J Clin Immunol"},{"issue":"7581","key":"957_CR37","doi-asserted-by":"publisher","first-page":"218","DOI":"10.1038\/nature15749","volume":"528","author":"S Cheloufi","year":"2015","unstructured":"Cheloufi S, Elling U, Hopfgartner B, Jung YL, Murn J, Ninova M, et al. The histone chaperone CAF-1 safeguards somatic cell identity. Nature. 2015;528(7581):218\u201324.","journal-title":"Nature."},{"issue":"11\u201312","key":"957_CR38","doi-asserted-by":"publisher","first-page":"669","DOI":"10.1101\/gad.322024.118","volume":"33","author":"C Ng","year":"2019","unstructured":"Ng C, Aichinger M, Nguyen T, Au C, Najar T, Wu L, et al. The histone chaperone CAF-1 cooperates with the DNA methyltransferases to maintain. Genes Dev. 2019;33(11\u201312):669\u201383.","journal-title":"Genes Dev"},{"issue":"3","key":"957_CR39","doi-asserted-by":"publisher","first-page":"549","DOI":"10.1016\/j.ajhg.2019.07.014","volume":"105","author":"M Bosticardo","year":"2019","unstructured":"Bosticardo M, Yamazaki Y, Cowan J, Giardino G, Corsino C, Scalia G, et al. Heterozygous FOXN1 variants cause low TRECs and severe T cell lymphopenia, revealing a crucial role of FOXN1 in supporting early thymopoiesis. Am J Hum Genet. 2019;105(3):549\u201361.","journal-title":"Am J Hum Genet"},{"issue":"3","key":"957_CR40","doi-asserted-by":"publisher","first-page":"126","DOI":"10.1007\/s12026-020-09131-x","volume":"68","author":"J Quinn","year":"2020","unstructured":"Quinn J, Modell V, Holle J, Truty R, Aradhya S, Johnson B, et al. Jeffrey\u2019s insights: Jeffrey Modell Foundation\u2019s global genetic sequencing pilot program to identify specific primary immunodeficiency defects to optimize disease management and treatment. Immunol Res. 2020;68(3):126\u201334.","journal-title":"Immunol Res"},{"issue":"1","key":"957_CR41","doi-asserted-by":"publisher","first-page":"46","DOI":"10.1016\/j.jaci.2019.09.009","volume":"145","author":"IK Chinn","year":"2020","unstructured":"Chinn IK, Chan AY, Chen K, Chou J, Dorsey MJ, Hajjar J, et al. Diagnostic interpretation of genetic studies in patients with primary immunodeficiency diseases: a working group report of the Primary Immunodeficiency Diseases Committee of the American Academy of Allergy, Asthma & Immunology. J Allergy Clin Immunol. 2020;145(1):46\u201369.","journal-title":"J Allergy Clin Immunol"},{"key":"957_CR42","doi-asserted-by":"publisher","unstructured":"Sullivan KE. The scary world of variants of uncertain significance (VUS): a hitchhiker\u2019s guide to interpretation. J Allergy Clin Immunol. 2020. https:\/\/doi.org\/10.1016\/j.jaci.2020.06.011.","DOI":"10.1016\/j.jaci.2020.06.011"},{"issue":"Suppl 1","key":"957_CR43","first-page":"S13","volume":"39","author":"S Zhang","year":"2019","unstructured":"Zhang S, Elshaigi O, Daian F, Bae E, Innamorato A, Navetta-Modrov B, et al. Describing single nucleotide polymorphisms (SNPs) transient T cell lymphopenia in the United States Immunodeficiency Network (USIDNET) following infants with low lymphocytes (FILL) program and a single referral center from 2010-2017. J Clin Immunol. 2019;39(Suppl 1):S13.","journal-title":"J Clin Immunol"},{"issue":"2","key":"957_CR44","doi-asserted-by":"publisher","first-page":"803","DOI":"10.1016\/j.jaip.2019.08.014","volume":"8","author":"MD Gans","year":"2020","unstructured":"Gans MD, Saavedra-Matiz CA, Bernstein L. A single nucleotide polymorphism in the T-cell receptor excision circle. J Allergy Clin Immunol Pract. 2020;8(2):803\u20135.e1.","journal-title":"J Allergy Clin Immunol Pract"},{"issue":"3","key":"957_CR45","doi-asserted-by":"publisher","first-page":"733","DOI":"10.1016\/j.jaci.2017.01.005","volume":"139","author":"MJ Dorsey","year":"2017","unstructured":"Dorsey MJ, Dvorak CC, Cowan MJ, Puck JM. Treatment of infants identified as having severe combined immunodeficiency by means of newborn screening. J Allergy Clin Immunol. 2017;139(3):733\u201342.","journal-title":"J Allergy Clin Immunol"},{"issue":"6","key":"957_CR46","doi-asserted-by":"publisher","first-page":"1674","DOI":"10.1016\/j.jaci.2019.05.038","volume":"144","author":"GS Amatuni","year":"2019","unstructured":"Amatuni GS, Sciortino S, Currier RJ, Naides SJ, Church JA, Puck JM. Reference intervals for lymphocyte subsets in preterm and term neonates without immune defects. J Allergy Clin Immunol. 2019;144(6):1674\u201383.","journal-title":"J Allergy Clin Immunol"},{"issue":"3","key":"957_CR47","doi-asserted-by":"publisher","first-page":"273","DOI":"10.1111\/j.1600-0609.1988.tb01192.x","volume":"41","author":"Y Shoenfeld","year":"1988","unstructured":"Shoenfeld Y, Alkan ML, Asaly A, Carmeli Y, Katz M. Benign familial leukopenia and neutropenia in different ethnic groups. Eur J Haematol. 1988;41(3):273\u20137.","journal-title":"Eur J Haematol"},{"key":"957_CR48","first-page":"318","volume":"1","author":"D Gitlin","year":"1956","unstructured":"Gitlin D, Janeway CA. Agammaglobulinemia, congenital, acquired and transient forms. Prog Hematol. 1956;1:318\u201329.","journal-title":"Prog Hematol"},{"issue":"2","key":"957_CR49","doi-asserted-by":"publisher","first-page":"287","DOI":"10.1182\/blood-2007-12-127878","volume":"112","author":"DI Zonios","year":"2008","unstructured":"Zonios DI, Falloon J, Bennett JE, Shaw PA, Chaitt D, Baseler MW, et al. Idiopathic CD4+ lymphocytopenia: natural history and prognostic factors. Blood. 2008;112(2):287\u201394.","journal-title":"Blood."},{"issue":"3","key":"957_CR50","doi-asserted-by":"publisher","first-page":"192","DOI":"10.1046\/j.1537-2995.1994.34394196614.x","volume":"34","author":"MP Busch","year":"1994","unstructured":"Busch MP, Valinsky JE, Paglieroni T, Prince HE, Crutcher GJ, Gjerset GF, et al. Screening blood donors for idiopthic CD4+ T-lymphocyotpenia. Transfusion. 1994;34(3):192\u20137.","journal-title":"Transfusion"},{"key":"957_CR51","doi-asserted-by":"publisher","first-page":"381","DOI":"10.1016\/B978-0-12-816768-7.00014-4","volume-title":"Stiehm\u2019s immune deficiencies","author":"A Lisco","year":"2020","unstructured":"Lisco A, Freeman AF, Sereti I. Idiopathic CD4 lymphopenia. In: Sullivan KE, Stiehm RE, editors. Stiehm\u2019s immune deficiencies. Second ed. London: Elsevier; 2020. p. 381\u201392.","edition":"Second"},{"issue":"4","key":"957_CR52","doi-asserted-by":"publisher","first-page":"389","DOI":"10.1097\/01.bor.0000231908.57913.2f","volume":"18","author":"UA Walker","year":"2006","unstructured":"Walker UA, Warnatz K. Idiopathic CD4 lymphocytopenia. Curr Opin Rheumatol. 2006;18(4):389\u201395.","journal-title":"Curr Opin Rheumatol"},{"issue":"2","key":"957_CR53","doi-asserted-by":"publisher","first-page":"61","DOI":"10.1097\/MD.0000000000000017","volume":"93","author":"A R\u00e9gent","year":"2014","unstructured":"R\u00e9gent A, Autran B, Carcelain G, Cheynier R, Terrier B, Charmeteau-De Muylder B, et al. Idiopathic CD4 lymphocytopenia: clinical and immunologic characteristics and follow-up of 40 patients. Medicine (Baltimore). 2014;93(2):61\u201372.","journal-title":"Medicine (Baltimore)"},{"issue":"1","key":"957_CR54","doi-asserted-by":"publisher","first-page":"198","DOI":"10.1016\/j.jaip.2016.09.028","volume":"5","author":"CY Kuo","year":"2017","unstructured":"Kuo CY, Garcia-Lloret MI, Slev P, Bohnsack JF, Chen K. Profound T-cell lymphopenia associated with prenatal exposure to purine antagonists detected by TREC newborn screening. J Allergy Clin Immunol Pract. 2017;5(1):198\u2013200.","journal-title":"J Allergy Clin Immunol Pract"}],"container-title":["Journal of Clinical Immunology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10875-020-00957-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s10875-020-00957-6\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10875-020-00957-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,4,18]],"date-time":"2022-04-18T03:44:44Z","timestamp":1650253484000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s10875-020-00957-6"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,1,7]]},"references-count":54,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2021,4]]}},"alternative-id":["957"],"URL":"https:\/\/doi.org\/10.1007\/s10875-020-00957-6","relation":{},"ISSN":["0271-9142","1573-2592"],"issn-type":[{"value":"0271-9142","type":"print"},{"value":"1573-2592","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,1,7]]},"assertion":[{"value":"17 July 2020","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"26 December 2020","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"7 January 2021","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with Ethical Standards"}},{"value":"The authors declare that they have no conflict of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of Interest"}},{"value":"The Northwell Health Institutional Review Board approved this study, Protocol 19-0150-CCMC.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical Approval"}},{"value":"The Northwell Health Institution Review Board granted a waiver of informed consent and assent for this study.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent to Participate"}},{"value":"Not applicable.","order":5,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent to Publish"}},{"value":"The Immune Deficiency Foundation had no input on study design, data collection or analysis, and manuscript preparation.","order":6,"name":"Ethics","group":{"name":"EthicsHeading","label":"Disclaimer"}}]}}